Nadim Ahmed - Dec 24, 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Nadim Ahmed
Stock symbol
CGEM
Transactions as of
Dec 24, 2024
Transactions value $
-$99,708
Form type
4
Date filed
12/27/2024, 06:00 PM
Previous filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$99.7K -8.4K -3.09% $11.87 263K Dec 24, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.